BioSpace News Archive

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that it has completed a medical manual that is pivotal to the completion of its Investigational New Drug application (IND) filing. The manual, “Angiography Manual – Transarterial Chemoinfusion of the Pa

A new study published in The Journal of Infectious Diseases showed high rates of GBS infection among the elderly, African Americans, and people with chronic conditions

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will make a virtual presentation at BofA Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 1:00 p.m. ET. The audio portion of the presentation will be available on the investors page of the Coherus BioSciences website at https://investors.coherus.com . About Coherus BioSciences, Inc. Coherus is a leading biosimilar company

Pandemic Has Exacerbated Long-Standing Issues Around Job-Induced Burnout, Stress, and Anxiety Among Nurses

Agadia Systems, Inc. (Agadia), a well-recognized innovator and provider of the utilization management suite of solutions, RxContinuum™, for Health Plans and PBMs, is pleased to announce the signing of an agreement with WellDyne, a leading pharmacy benefit manager, to leverage PAHub™, Agadia’s HITRUST certified, Prior Authorization management solution.

Building a successful business amid the crisis poses a huge challenge for pharma and life sciences companies. To address this issue, Quantzig, a global data analytics and advisory firm, has devised a customized portfolio of advanced business continuity planning solutions for pharma and life sciences companies.

Governments are hoarding more than 100 million doses of hydroxychloroquine (HCQ) while victims of COVID-19 are dying from lack of early treatment, which an increasing number of physicians and scientists believe is crucial for saving lives. In many places, particularly in nursing homes

Illinois Bone & Joint Institute (IBJI), the largest independent, physician-owned orthopedic practice in Illinois, is preparing to reopen for elective surgeries and musculoskeletal procedures.

Liberate Medical today announced that it has received Federal Drug Administration (FDA) Emergency Use Authorization for its VentFree™ Respiratory Muscle Stimulator, intended to be used to reduce disuse atrophy of the abdominal wall muscles, which may reduce the number of days adult patients require mechanical ventilation, including those patients with COVID-19.

Diverse Biotech, Inc. www.diversebiotech.com has announced the U.S. Food & Drug Administration (FDA) has granted an orphan-drug designation request for one of its investigational new therapies for treatment of newly diagnosed glioblastoma, in conjunction with standard treatment, following adjuvant combined chemo-radiation.